Gamble Jones Investment Counsel Gsk PLC Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	BUY	$40.23 - $47.74 $106,609 - $126,511	2,650 Added 24.72%	13,368 $582,000
Q4 2021 Feb 09, 2022	BUY	$38.88 - $45.31 $3,888 - $4,531	100 Added 0.94%	10,718 $473,000
Q3 2021 Nov 09, 2021	SELL	$38.79 - $43.16 $15,516 - $17,264	-400 Reduced 3.63%	10,618 $406,000
Q2 2021 Aug 06, 2021	BUY	$36.52 - $41.46 $5,478 - $6,219	150 Added 1.38%	11,018 $439,000
Q1 2021 May 10, 2021	SELL	$34.27 - $40.01 $62,645 - $73,138	-1,828 Reduced 14.4%	10,868 $388,000
Q3 2020 Nov 10, 2020	SELL	$38.11 - $42.99 $38 - $42	-1 Reduced 0.01%	12,696 $478,000
Q1 2020 May 08, 2020	SELL	$32.47 - $48.83 $12,630 - $18,994	-389 Reduced 2.97%	12,697 $481,000
Q4 2019 Feb 10, 2020	SELL	$42.0 - $48.25 $114,744 - $131,819	-2,732 Reduced 17.27%	13,086 $615,000
Q3 2019 Nov 04, 2019	BUY	$40.46 - $43.52 $445 - $478	11 Added 0.07%	15,818 $675,000
Q2 2019 Aug 20, 2019	SELL	$39.4 - $42.7 $28,052 - $30,402	-712 Reduced 4.31%	15,807 $633,000
Q1 2019 May 02, 2019	BUY	$38.57 - $42.69 $4,281 - $4,738	111 Added 0.68%	16,519 $690,000
Q4 2018 Feb 04, 2019	SELL	$37.8 - $42.69 $97,939 - $110,609	-2,591 Reduced 13.64%	16,408 $627,000
Q3 2018 Nov 06, 2018	SELL	$39.75 - $42.69 $11,805 - $12,678	-297 Reduced 1.54%	18,999 $763,000
Q2 2018 Aug 03, 2018	SELL	$39.61 - $42.76 $34,302 - $37,030	-866 Reduced 4.3%	19,296 $778,000
Q1 2018 May 10, 2018	SELL	$36.18 - $40.15 $3,835 - $4,255	-106 Reduced 0.52%	20,162 $788,000
Q4 2017 Feb 06, 2018	SELL	$35.34 - $41.9 $2,332 - $2,765	-66 Reduced 0.32%	20,268 $719,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $801,972 - $844,877	20,334	20,334 $826,000

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account